Estrogen Antagonists

"Estrogen Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds.

Descriptor ID	D004965
MeSH Number(s)	D06.347.295 D27.505.696.399.450.327
Concept/Terms	Estrogen Antagonists Estrogen Antagonists Antagonists, Estrogen Estradiol Antagonists Estradiol Antagonists Antagonists, Estradiol

Below are MeSH descriptors whose meaning is more general than "Estrogen Antagonists".

Chemicals and Drugs [D]
Hormones, Hormone Substitutes, and Hormone Antagonists [D06]
Hormone Antagonists [D06.347]
Estrogen Antagonists [D06.347.295]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Hormones, Hormone Substitutes, and Hormone Antagonists [D27.505.696.399]
Hormone Antagonists [D27.505.696.399.450]
Estrogen Antagonists [D27.505.696.399.450.327]

Below are MeSH descriptors whose meaning is related to "Estrogen Antagonists".

Below are MeSH descriptors whose meaning is more specific than "Estrogen Antagonists".

Estrogen Antagonists
Estrogen Receptor Antagonists

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Estrogen Antagonists" by people in this website by year, and whether "Estrogen Antagonists" was a major or minor topic of these publications.

Bar chart showing 11 publications over 10 distinct years, with a maximum of 2 publications in 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
2000	0	1	1
2001	1	0	1
2002	1	0	1
2007	1	0	1
2008	0	2	2
2010	0	1	1
2012	1	0	1
2015	0	1	1
2016	1	0	1

Below are the most recent publications written about "Estrogen Antagonists" by people in Profiles.

Berghella V, Boelig RC. Always ask why! Am J Obstet Gynecol. 2016 Mar; 214(3):303-5.

View in: PubMed
Pike S, Zhang P, Wei Z, Wu N, Klinger A, Chang S, Jones R, Carpenter J, Brown SA, DiMuzio P, Tulenko T, Liu Y. In vitro effects of tamoxifen on adipose-derived stem cells. Wound Repair Regen. 2015 Sep; 23(5):728-36.

View in: PubMed
Rahimy E, Sarraf D. Bevacizumab therapy for tamoxifen-induced crystalline retinopathy and severe cystoid macular edema. Arch Ophthalmol. 2012 Jul; 130(7):931-2.

View in: PubMed
Balaburski GM, Dardes RC, Johnson M, Haddad B, Zhu F, Ross EA, Sengupta S, Klein-Szanto A, Liu H, Lee ES, Kim H, Jordan VC. Raloxifene-stimulated experimental breast cancer with the paradoxical actions of estrogen to promote or prevent tumor growth: a unifying concept in anti-hormone resistance. Int J Oncol. 2010 Aug; 37(2):387-98.

View in: PubMed
Novotny JL, Simpson AM, Tomicek NJ, Lancaster TS, Korzick DH. Rapid estrogen receptor-alpha activation improves ischemic tolerance in aged female rats through a novel protein kinase C epsilon-dependent mechanism. Endocrinology. 2009 Feb; 150(2):889-96.

View in: PubMed
Raake PW, Vinge LE, Gao E, Boucher M, Rengo G, Chen X, DeGeorge BR, Matkovich S, Houser SR, Most P, Eckhart AD, Dorn GW, Koch WJ. G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure. Circ Res. 2008 Aug 15; 103(4):413-22.

View in: PubMed
Riggins RB, Schrecengost RS, Guerrero MS, Bouton AH. Pathways to tamoxifen resistance. Cancer Lett. 2007 Oct 18; 256(1):1-24.

View in: PubMed
Brady H, Doubleday M, Gayo-Fung LM, Hickman M, Khammungkhune S, Kois A, Lipps S, Pierce S, Richard N, Shevlin G, Sutherland MK, Anderson DW, Bhagwat SS, Stein B. Differential response of estrogen receptors alpha and beta to SP500263, a novel potent selective estrogen receptor modulator. Mol Pharmacol. 2002 Mar; 61(3):562-8.

View in: PubMed
Ma XL, Gao F, Chen J, Christopher TA, Lopez BL, Ohlstein EH, Yue T. Endothelial protective and antishock effects of a selective estrogen receptor modulator in rats. Am J Physiol Heart Circ Physiol. 2001 Feb; 280(2):H876-84.

View in: PubMed
Minjarez DA, Schlaff WD. Update on the medical treatment of endometriosis. Obstet Gynecol Clin North Am. 2000 Sep; 27(3):641-51.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement